Malaysia in Focus - ARNI Data and its Implications on Clinical Practice
Published: 09 September 2020
-
Views:
2608
-
Likes:
7
-
Views:
2608
-
Likes:
7
-
Up Next
-
5m 28sPart 3 | Session 1 Local Interpretation of Emerging ARNI Data in HF
-
18m 26sPart 3 | Session 2 ARNI Therapy Mode of Action
-
7m 1sPart 3 | Session 3 Safety and Efficacy of ARNI Therapy in Acute Heart Failure
-
8m 35sPart 3 | Session 4 When to Initiate ARNI Therapy in Acute Heart Failure
-
2m 19sPart 3 | Session 5 Summary
-
31m 13sPart 1 | Session 1 Meet the Expert Presentation Carolyn Lam, Wan Azman Wan Ahmad
-
27m 18sPart 1 | Session 2 Meet the Expert Q&A Carolyn Lam, Wan Azman Wan Ahmad
Overview
This educational programme focuses on placing recent data on ARNIs in Heart Failure into perspective for a Malaysian audience
More from this programme
Part 1
Local Interpretation of Emerging ARNI Data in HF
Part 2
Managing Hypotension in Patients with HFrEF (Utilising ARNIs)
| 1 session | |
| Expert Interview | Watch now |
Part 3
Clinical Questions on ARNI therapy
Faculty Biographies
Carolyn Lam
Professor and Senior Consultant
Prof Carolyn Lam is a Senior Consultant at the Department of Cardiology and Director of Women's Heart Health at the National Heart Centre Singapore, having pioneered the first Women’s Heart Clinic in Singapore. Prof Lam is a world-renowned specialist in heart failure (particularly heart failure with preserved ejection fraction [HFpEF]). Her work in the PARAGON-HF and EMPEROR-Preserved trials led to the first FDA-approved treatment for HFpEF and the first robustly positive clinical outcomes trial in HFpEF to-date.